T 1063/06 (Reach-through claim/BAYER SCHERING PHARMA AKTIENGESELLSCHAFT) of 03.02.2009
- European Case Law Identifier
- ECLI:EP:BA:2009:T106306.20090203
- Date of decision
- 3 February 2009
- Case number
- T 1063/06
- Petition for review of
- -
- Application number
- 00962413.1
- IPC class
- C07C 69/76
- Language of proceedings
- German
- Distribution
- Published in the EPO's Official Journal (A)
- Download
- Decision in German
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
- Applicant name
- Bayer Schering Pharma Aktiengesellschaft
- Opponent name
- -
- Board
- 3.3.10
- Headnote
I. A formulation of a claim whereby functionally defined chemical compounds are to be found by means of a new kind of research tool using a screening method set out in the description constitutes a reach-through claim which is also directed to future inventions based on the one now being disclosed. As the applicant is entitled to claim patent protection only for his actual contribution to the art, it is therefore both reasonable and imperative to limit the claim's subject-matter accordingly. Patent protection under the EPC is not designed for the purpose of reserving an unexplored field of research for a particular applicant, as reach-through claims do, but to protect factual results of successful research as a reward for making concrete technical results available to the public.
II. A functional definition of a chemical compound (in this case in a reach-through claim) covers all compounds possessing the capability according to the claim. In the absence of any selection rule in the application in suit, the skilled person, without the possibility of having recourse to his common general knowledge, must resort to trial-and-error experimentation on arbitrarily selected chemical compounds to establish whether they possess the capability according to the claim; this represents for the skilled person an invitation to perform a research programme and thus an undue burden (following T 435/91).
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 83
- Keywords
- All requests: reach-through claim - chemical compounds defined in functional terms - future inventions also claimed - limiting claim to actual contribution to the art both reasonable and imperative - invention cannot be carried out within the entire scope claimed without undue effort - research programme
- Catchword
- -
ORDER
For these reasons it is decided that:
The appeal is dismissed.